Barclays Forecasts Strong Price Appreciation for Boston Scientific (NYSE:BSX) Stock
Boston Scientific (NYSE:BSX – Free Report) had its price objective upped by Barclays from $111.00 to $118.00 in a report published on Monday,Benzinga reports. The firm currently has an overweight rating on the medical equipment provider’s stock. A number of other research firms also recently commented on BSX. Needham & Company LLC reaffirmed a “hold” […]
Boston Scientific (NYSE:BSX – Free Report) had its price objective upped by Barclays from $111.00 to $118.00 in a report published on Monday,Benzinga reports. The firm currently has an overweight rating on the medical equipment provider’s stock. A number of other research firms also recently commented on BSX. Needham & Company LLC reaffirmed a “hold” […]
